Trending Posts

Recent in news
Can DeepMind’s Demis Hassabis Slash Drug Discovery Timelines…

Key Highlights: What Hassabis Says: A Turning Point for Drug DiscoveryDemis Hassabis, CEO of DeepMind, recently told Bloomberg…

ByByAnuja SinghSep 12, 2025
Will AbbVie’s Rinvoq Patent Deal Lock Out Generics…

Key Highlights: Patent Shield Extended Through SettlementsAbbVie has successfully resolved litigation with multiple generic challengers—including Sandoz, Aurobindo, Intas,…

ByByAnuja SinghSep 12, 2025
Will Johnson & Johnson’s FDA Approval of INLEXZO™…

Key Highlights: A Breakthrough in Bladder Cancer TreatmentThe U.S. FDA has approved INLEXZO™ (gemcitabine intravesical system), marking the…

ByByAnuja SinghSep 12, 2025
Could Johnson & Johnson’s MARIPOSA Trial with RYBREVANT®…

Key Highlights: Clinical Breakthrough in EGFR-Mutated NSCLCJohnson & Johnson’s Innovative Medicine segment has announced positive results from the…

ByByAnuja SinghSep 12, 2025
Can Novo Nordisk’s New Semaglutide and Obesity Pipeline…

Key Highlights: Scientific Momentum at EASD 2025Novo Nordisk will present 35 abstracts across its diabetes and obesity portfolio…

ByByAnuja SinghSep 11, 2025
Could Pfizer and BioNTech’s LP.8.1-Adapted COMIRNATY® Redefine COVID-19…

Key Insights: Robust Phase 3 Findings for High-Risk PopulationsThe topline results from the Phase 3 clinical trial included…

ByByAnuja SinghSep 11, 2025
Will Merck’s CAPVAXIVE® 21-Valent Vaccine Set a New…

Key Highlights Promising Phase 3 Data from STRIDE-13 TrialMerck announced that CAPVAXIVE demonstrated robust immunogenicity and safety in…

ByByAnuja SinghSep 11, 2025
Could Sanofi’s One-Time Gene Therapy SAR402663 Transform Treatment…

Key Highlights A Major Step Forward in Retinal Disease InnovationThe FDA’s Fast Track designation underscores the urgent need…

ByByAnuja SinghSep 11, 2025
Is Lilly’s “TuneLab” the Breakthrough AI Collaboration Model…

Key Highlights A bold move: Lilly democratizes AI for biotechEli Lilly has launched TuneLab, a novel AI platform…

ByByAnuja SinghSep 10, 2025

Latest Stories

Don’t miss our hot and upcoming stories
Is Novartis Deepening Its Bet on AI-Enabled Molecular Glue Degraders Through an Expanded Collaboration With Monte Rosa?

Novartis AG (SIX: NOVN; NYSE: NVS), a global leader in immunology and targeted therapies, has…

ByByAnuja SinghSep 16, 2025
Will Levita’s MARS Platform Redefine Solo Surgery with Autonomous Camera Integration?

Key Highlights: Autonomous Camera Enables Solo Laparoscopic Surgery At Clínica Las Condes in Santiago, Chile,…

ByByAnuja SinghSep 15, 2025
Will the FDA’s Panel Shape the Future of AI-Mental Health Tools?

Key Highlights: Advisory Meeting to Tackle Generative AI in Mental Health The FDA has formally…

ByByAnuja SinghSep 15, 2025
Will Tempus AI’s FDA Clearance Redefine the Future of Cardiac Imaging?

Key Highlights: Tempus AI Secures FDA Clearance for Tempus Pixel Tempus AI announced that its…

ByByAnuja SinghSep 15, 2025
Scroll to Top